Notice Pursuant to the National Cooperative Research and Production Act of 1993-Open Source Imaging Consortium, Inc., 14973 [2019-07255]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 71 / Friday, April 12, 2019 / Notices
Register pursuant to Section 6(b) of the
Act on October 26, 2018 (83 FR 54142).
Register pursuant to Section 6(b) of the
Act on January 31, 2019 (84 FR 795).
further the purposes and achieve the
goals set forth above.
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2019–07256 Filed 4–11–19; 8:45 am]
[FR Doc. 2019–07258 Filed 4–11–19; 8:45 am]
[FR Doc. 2019–07255 Filed 4–11–19; 8:45 am]
BILLING CODE 4410–11–P
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Antitrust Division
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Open Source Imaging
Consortium, Inc.
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Silicon Integration
Initiative, Inc.
Notice is hereby given that, on March
20, 2019, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Open Source
Imaging Consortium, Inc. has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
(1) the identities of the parties to the
venture and (2) the nature and
objectives of the venture. The
notifications were filed for the purpose
of invoking the Act’s provisions limiting
the recovery of antitrust plaintiffs to
actual damages under specified
circumstances.
Pursuant to Section 6(b) of the Act,
the identities of the parties to the
venture are: Boehringer Ingelheim USA
Corporation, Ridgefield, CT; Three
Lakes Partners, Northbrook, IL; Siemens
Healthcare GmbH, Erlangen,
GERMANY; and Fluidda NV,
Groeningenlei, BELGIUM. The general
area of Open Source Imaging
Consortium, Inc.’s planned activity is to
define digital imaging biomarkers for
idiopathic pulmonary fibrosis and
fibrotic interstitial lung diseases (the
‘‘Medical Conditions’’) in order to
ensure accurate imaging-based
diagnosis, prognosis and prediction of
response to therapy, including: (a)
Enabling the effective sharing,
utilization, and analysis of data relating
to the Medical Conditions;(b)
establishing and sustaining Open
Source Imaging Consortium, Inc. as the
preferred data sharing and analytics
platform for research relating to the
Medical Conditions;(c) link academic,
non-profit and corporate research
communities for collaborative research
facilitated by Open Source Imaging
Consortium, Inc.;(d) align and grow a
vibrant network of researchers and
developers around the goals of Open
Source Imaging Consortium, Inc.; and
(e) undertaking such other activities as
may from time to time be appropriate to
Notice is hereby given that, on March
18, 2019, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Silicon Integration
Initiative, Inc. (‘‘Si2’’) filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Agile Analog LTD,
Cambridgeshire, UNITED KINGDOM;
Avatar Integrated Systems, Santa Clara,
CA; Blue Cheetah Analog Design, Palo
Alto, CA; Chengdu Higon IC Design Co.,
Ltd., Beijing, PEOPLE’S REPUBLIC OF
CHINA; and D2S, Inc., San Jose, CA,
have been added as parties to this
venture.
Also, Atoptech, Inc., Santa Clara, CA;
Juniper Networks, San Diego, CA; D.E.
Shaw Research, New York, NY; eASIC
Corporation, Santa Clara, CA; EDXACT,
Voiron, FRANCE; Fraunhofer Institute
for Integrated Circuits IIS, Dresden,
GERMANY; IC Manage, Inc., Campbell,
CA; MINALOGIC, Grenoble, FRANCE;
Oracle Corporation, Redwood City, CA;
Peregrine Semiconductor Corporation,
San Diego, CA; RICOH Electronic
Devices Company, LTD, Tokyo, JAPAN;
Sage Design
Automation, Santa Clara, CA; and
Teklatech A/S, Frederiksberg,
DENMARK, have withdrawn as parties
to this venture.
In addition, the following member has
changed its name: Thermo-Fisher
Scientific, Inc. to Life Technologies
Corporation, Carlsbad, CA.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and Si2 intends to
file additional written notifications
disclosing all changes in membership.
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Advanced Media
Workflow Association, Inc.
jbell on DSK30RV082PROD with NOTICES
14973
Notice is hereby given that, on March
21, 2019, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Advanced Media
Workflow Association, Inc. has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
Bridge Technologies Co AS, Oslo,
NORWAY; TSL Products, Marlow,
UNITED KINGDOM; and TAG Video
Systems, Tel Aviv, ISRAEL, have been
added as parties to this venture.
Also, Korean Broadcasting System,
Seoul, REPUBLIC OF KOREA; and
Streampunk Media, Aultbea, UNITED
KINGDOM, have withdrawn as parties
to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and Advanced
Media Workflow Association, Inc.
intends to file additional written
notifications disclosing all changes in
membership.
On March 28, 2000, Advanced Media
Workflow Association, Inc. filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on March 28, 2000 (65 FR 40127).
The last notification was filed with
the Department on December 13, 2018.
A notice was published in the Federal
VerDate Sep<11>2014
18:18 Apr 11, 2019
Jkt 247001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
E:\FR\FM\12APN1.SGM
12APN1
]]>Agencies
[Federal Register Volume 84, Number 71 (Friday, April 12, 2019)]
[Notices]
[Page 14973]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07255]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Open Source Imaging Consortium, Inc.
Notice is hereby given that, on March 20, 2019, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Open Source Imaging Consortium,
Inc. has filed written notifications simultaneously with the Attorney
General and the Federal Trade Commission disclosing (1) the identities
of the parties to the venture and (2) the nature and objectives of the
venture. The notifications were filed for the purpose of invoking the
Act's provisions limiting the recovery of antitrust plaintiffs to
actual damages under specified circumstances.
Pursuant to Section 6(b) of the Act, the identities of the parties
to the venture are: Boehringer Ingelheim USA Corporation, Ridgefield,
CT; Three Lakes Partners, Northbrook, IL; Siemens Healthcare GmbH,
Erlangen, GERMANY; and Fluidda NV, Groeningenlei, BELGIUM. The general
area of Open Source Imaging Consortium, Inc.'s planned activity is to
define digital imaging biomarkers for idiopathic pulmonary fibrosis and
fibrotic interstitial lung diseases (the ``Medical Conditions'') in
order to ensure accurate imaging-based diagnosis, prognosis and
prediction of response to therapy, including: (a) Enabling the
effective sharing, utilization, and analysis of data relating to the
Medical Conditions;(b) establishing and sustaining Open Source Imaging
Consortium, Inc. as the preferred data sharing and analytics platform
for research relating to the Medical Conditions;(c) link academic, non-
profit and corporate research communities for collaborative research
facilitated by Open Source Imaging Consortium, Inc.;(d) align and grow
a vibrant network of researchers and developers around the goals of
Open Source Imaging Consortium, Inc.; and (e) undertaking such other
activities as may from time to time be appropriate to further the
purposes and achieve the goals set forth above.
Suzanne Morris,
Chief, Premerger and Division Statistics Unit, Antitrust Division.
[FR Doc. 2019-07255 Filed 4-11-19; 8:45 am]
BILLING CODE 4410-11-P
